Rifaximin - PDFSEARCH.IO - Document Search Engine

Rifaximin
Results: 32

#	Item
11	GI Drugs Advisory Committee Meeting NDA[removed]Xifaxan (Rifaximin) Ruyi He, MD Acting Deputy Director Division of Gastroenterology Products Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Clinical research Ethers Lactams Rifaximin Clinical trial Pharmaceutical sciences Health Food and Drug Administration
12	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Clinical pharmacology Food and Drug Administration Ethers Lactams Rifaximin Center for Drug Evaluation and Research Drug discovery Pharmaceutical sciences Pharmacology Medicinal chemistry
13	Briefing Package - Errata Add to Reading List Source URL: www.fda.gov Language: English Medicinal chemistry Pharmacology HERG Rifaximin IC50 In vitro Medicine Chemistry Pharmaceutical sciences Ion channels
14	Microsoft Word - HE briefing doc draft_20Jan2010_final.doc Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmacology Bioethics Medical ethics Design of experiments Rifaximin Irritable bowel syndrome Clostridium difficile Placebo Medicine Health Science
15	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Meeting of the Gastrointestinal Drugs Advisory Committee(GIDAC) February 23, 2010 AGENDA Add to Reading List Source URL: www.fda.gov Language: English Clinical research Drug safety Pharmaceutical industry Rifaximin New Drug Application Food and Drug Administration Pharmaceutical sciences Pharmacology
16	DEPARTMENT OF HEALTH AND HUMAN SERVICES UNITED STATES FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH GASTROINTESTINAL DRUGS ADVISORY COMMITTEE Add to Reading List Source URL: www.fda.gov Language: English Ethers Lactams Rifaximin Food and Drug Administration Pharmaceutical sciences Chemistry Clinical research
17	Summary Minutes of the Gastrointestinal Drugs Advisory Committee (GIDAC) Meeting Holiday Inn Washington/College Park, College Park, Maryland November 16, 2011 All external requests for the meeting transcript should be su Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Ethers Lactams Rifaximin Irritable bowel syndrome Center for Drug Evaluation and Research Adverse effect Health Medicine Pharmacology
18	Michigan Collaborative Standardization of Compounded Oral Liquids Drug name: Rifaximin Dosage Form: Add to Reading List Source URL: www.mipedscompounds.org Language: English - Date: 2014-01-24 20:16:10 Lactams Ethers Rifaximin Medical prescription V Chemistry Organic chemistry Medicine
19	nature publishing group ERRATA, CORRIGENDA AND RETRACTIONS Corrigendum: An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome Add to Reading List Source URL: www.nature.com Language: English - Date: 2010-03-10 16:03:16 Abdominal pain General practice Irritable bowel syndrome Syndromes Rifaximin Diarrhea Chronic functional abdominal pain Rome process Medicine Health Gastroenterology
20	Summary Minutes of the Gastrointestinal Drugs Advisory Committee (GIDAC) February 23, 2010 Hilton Washington, DC/Silver Spring The Ballrooms, 8727 Colesville Road, Silver Spring, Maryland All external requests for the me Add to Reading List Source URL: www.fda.gov Language: English Health Orphan drugs Ethers Lactams Rifaximin Center for Drug Evaluation and Research Hepatic encephalopathy Medicine Food and Drug Administration Pharmaceutical sciences

UPDATE